Risk factors to identify patients who may not benefit from whole brain irradiation for brain metastases - a single institution analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1748-717X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Risk factors to identify patients who may not benefit from whole brain irradiation for brain metastases - a single institution analysis ; volume:14 ; number:1 ; day:11 ; month:3 ; year:2019 ; pages:1-6 ; date:12.2019
Radiation oncology ; 14, Heft 1 (11.3.2019), 1-6, 12.2019
- Urheber
-
Buecker, Rebecca
Hong, Zhen-Yu
Liu, Xiao-Mei
Jaenke, Gert
Lu, Ping
Schaefer, Ulrich
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13014-019-1245-9
- URN
-
urn:nbn:de:101:1-2019040701261951986119
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Buecker, Rebecca
- Hong, Zhen-Yu
- Liu, Xiao-Mei
- Jaenke, Gert
- Lu, Ping
- Schaefer, Ulrich
- SpringerLink (Online service)
Ähnliche Objekte (12)
PRO: do we still need whole-brain irradiation for brain metastases?
The benefit of whole brain reirradiation in patients with multiple brain metastases
Comparison of whole brain radiation therapy for synchronous brain metastases with irradiation protecting the hippocampus versus whole brain radiotherapy for sequential brain metastases to boost irradiation in the treatment of brain metastases from SCLC: study protocol for a randomized controlled trial
Management of brain metastases with stereotactic radiosurgery alone versus whole brain irradiation alone versus both
Risk factors for brain metastases in completely resected small cell lung cancer: a retrospective study to identify patients most likely to benefit from prophylactic cranial irradiation
Current status and recent advances in resection cavity irradiation of brain metastases
Single isocenter stereotactic irradiation for multiple brain metastases: current situation and prospects
Phase II randomized, double-blind, placebo-controlled study of whole-brain irradiation with concomitant chloroquine for brain metastases
Prognostic factors for outcomes after whole-brain irradiation of brain metastases from relatively radioresistant tumors: a retrospective analysis
Brain metastases from hepatopancreatobiliary malignancies
Current management of brain metastases
Treatment Options for Brain Metastases
PRO: do we still need whole-brain irradiation for brain metastases?
The benefit of whole brain reirradiation in patients with multiple brain metastases
Comparison of whole brain radiation therapy for synchronous brain metastases with irradiation protecting the hippocampus versus whole brain radiotherapy for sequential brain metastases to boost irradiation in the treatment of brain metastases from SCLC: study protocol for a randomized controlled trial
Management of brain metastases with stereotactic radiosurgery alone versus whole brain irradiation alone versus both
Risk factors for brain metastases in completely resected small cell lung cancer: a retrospective study to identify patients most likely to benefit from prophylactic cranial irradiation
Current status and recent advances in resection cavity irradiation of brain metastases
Single isocenter stereotactic irradiation for multiple brain metastases: current situation and prospects
Phase II randomized, double-blind, placebo-controlled study of whole-brain irradiation with concomitant chloroquine for brain metastases
Prognostic factors for outcomes after whole-brain irradiation of brain metastases from relatively radioresistant tumors: a retrospective analysis
Brain metastases from hepatopancreatobiliary malignancies
Current management of brain metastases
Treatment Options for Brain Metastases
PRO: do we still need whole-brain irradiation for brain metastases?
The benefit of whole brain reirradiation in patients with multiple brain metastases
Comparison of whole brain radiation therapy for synchronous brain metastases with irradiation protecting the hippocampus versus whole brain radiotherapy for sequential brain metastases to boost irradiation in the treatment of brain metastases from SCLC: study protocol for a randomized controlled trial
Management of brain metastases with stereotactic radiosurgery alone versus whole brain irradiation alone versus both
Risk factors for brain metastases in completely resected small cell lung cancer: a retrospective study to identify patients most likely to benefit from prophylactic cranial irradiation
Current status and recent advances in resection cavity irradiation of brain metastases
Single isocenter stereotactic irradiation for multiple brain metastases: current situation and prospects
Phase II randomized, double-blind, placebo-controlled study of whole-brain irradiation with concomitant chloroquine for brain metastases
Prognostic factors for outcomes after whole-brain irradiation of brain metastases from relatively radioresistant tumors: a retrospective analysis
Brain metastases from hepatopancreatobiliary malignancies
Current management of brain metastases